• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP HBSAG CONFIRMATORY (CONF) ASSAY; HBSAG CONFIRMATORY IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP HBSAG CONFIRMATORY (CONF) ASSAY; HBSAG CONFIRMATORY IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem Venipuncture (2129)
Event Date 08/20/2014
Event Type  malfunction  
Event Description
Customer observed a (b)(6) advia centaur xp (b)(6) result that confirmed reactive with the advia centaur (b)(4) confirmatory assay.The physician requested a re-draw of the patient samples.There are no reports that treatment was altered or prescribed or adverse health consequences based on the discordant reactive results.
 
Manufacturer Narrative
The cause of the (b)(6) advia centaur xp (b)(6) confirmed by the advia centaur xp (b)(4) conf test is unknown.The customer noted that the advia centaur xp (b)(4) and the advia centaur xp (b)(4) confirmatory test were not calibrated on the same day as instructed in the instructions for use.No conclusions can be drawn.The customer cannot rule out preanalytical error.The sample is no longer available.The customer declined service and feels that the issue was specific to this sample.The limitations section of the instructions for use states:" for diagnostic purposes and to differentiate between acute and chronic hbv infection, the detection of (b)(6) should be correlated with patient clinical information and other hbv serological markers.It is recognized that presently available methods for detection of hepatitis b surface antigen may not detect all potentially infected individuals.A (b)(6) test result or invalid confirmatory result does not exclude the possibility of exposure to or infection with (b)(6).".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP HBSAG CONFIRMATORY (CONF) ASSAY
Type of Device
HBSAG CONFIRMATORY IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
5086604381
MDR Report Key4224015
MDR Text Key21724501
Report Number1219913-2014-00261
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Health Professional
Remedial Action Inspection
Type of Report Initial
Report Date 10/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2015
Device Model NumberN/A
Device Catalogue Number03393818
Device Lot Number31196
Other Device ID NumberN/A
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/10/2014
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-